The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.
Availability of Tamiflu for Oral Suspension (12/11/2009)
Updated Safety Information about a drug interaction between Clopidogrel Bisulfate (marketed as Plavix) and Omeprazole (marketed as Prilosec and Prilosec OTC) (11/17/2009)
The FDA recommends that consumers should not use body building products marketed as containing steroids or steroid-like substances (7/28/2009)
FDA Requires New Boxed Warnings for the Smoking Cessation Drugs Chantix and Zyban (7/1/2009)
Loss of Sense of Smell with Intranasal Cold Remedies Containing Zinc (06/16/2009)
Public Health Advisory: Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings (03/05/2009)
FDA issues Updated Safety Information about Raptiva (efalizumab) (02/19/2009)
Potential Hazards of Skin Products Containing Numbing Ingredients for Relieving Pain from Mammography and Other Medical Tests and Conditions (01/16/2009)
Page Last Updated: 08/19/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.